159 related articles for article (PubMed ID: 17310323)
1. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
Zawacka-Pankau J; Podhajska AJ
Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy.
Zawacka-Pankau J; Kowalska A; Issaeva N; Burcza A; Kwiek P; Bednarz N; Pramanik A; Banecki B; Podhajska AJ
J Photochem Photobiol B; 2007 Jan; 86(1):35-42. PubMed ID: 16990010
[TBL] [Abstract][Full Text] [Related]
3. Expression in Escherichia coli and simple purification of human Fhit protein.
Pawelczyk T; Kowara R; Golebiowski F; Matecki A
Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
[TBL] [Abstract][Full Text] [Related]
4. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
5. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
7. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
[TBL] [Abstract][Full Text] [Related]
8. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
[TBL] [Abstract][Full Text] [Related]
9. Control of 5',5'-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT.
Chen J; Brevet A; Blanquet S; Plateau P
J Bacteriol; 1998 May; 180(9):2345-9. PubMed ID: 9573184
[TBL] [Abstract][Full Text] [Related]
10. Enlightened protein: Fhit tumor suppressor protein structure and function and its role in the toxicity of protoporphyrin IX-mediated photodynamic reaction.
Zawacka-Pankau J; Ferens B
Toxicol Appl Pharmacol; 2009 Dec; 241(2):246-52. PubMed ID: 19716840
[TBL] [Abstract][Full Text] [Related]
11. Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit.
Ferens B; Kawiak A; Banecki B; Bielawski KP; Zawacka-Pankau J
Cancer Lett; 2009 Jul; 280(1):101-9. PubMed ID: 19286306
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
[TBL] [Abstract][Full Text] [Related]
13. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.
Shi Y; Zou M; Farid NR; Paterson MC
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):443-8. PubMed ID: 11085938
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.
Huang K; Arabshahi A; Wei Y; Frey PA
Biochemistry; 2004 Jun; 43(23):7637-42. PubMed ID: 15182206
[TBL] [Abstract][Full Text] [Related]
15. Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.
Brenner C; Pace HC; Garrison PN; Robinson AK; Rosler A; Liu XH; Blackburn GM; Croce CM; Huebner K; Barnes LD
Protein Eng; 1997 Dec; 10(12):1461-3. PubMed ID: 9543008
[TBL] [Abstract][Full Text] [Related]
16. Chemical Proteomics of the Tumor Suppressor Fhit Covalently Bound to the Cofactor Ap
Herzog D; Jansen J; Mißun M; Diederichs K; Stengel F; Marx A
J Am Chem Soc; 2022 May; 144(19):8613-8623. PubMed ID: 35522782
[TBL] [Abstract][Full Text] [Related]
17. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
18. New interactions between tumor suppressor Fhit protein and a nonhydrolyzable analog of its A
Krakowiak A; Kocoń-Rębowska B; Dolot R; Piotrzkowska D
FEBS Lett; 2017 Feb; 591(3):548-559. PubMed ID: 28094435
[TBL] [Abstract][Full Text] [Related]
19. The tumor suppressor protein Fhit. A novel interaction with tubulin.
Chaudhuri AR; Khan IA; Prasad V; Robinson AK; Ludueña RF; Barnes LD
J Biol Chem; 1999 Aug; 274(34):24378-82. PubMed ID: 10446217
[TBL] [Abstract][Full Text] [Related]
20. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate.
Murphy GA; Halliday D; McLennan AG
Cancer Res; 2000 May; 60(9):2342-4. PubMed ID: 10811104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
